Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vixotrigine for Trigeminal Neuralgia
NCT03637387Phase 3Withdrawn
- Sponsor
- Biogen
- Start
- Mar 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of vixotrigine in trigeminal neuralgia (TN), sponsored by Biogen. Planned start Mar 2023; status: withdrawn.
02
Drugs
vixotrigine
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT03637387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03637387.